Anthos Therapeutics, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Anthos Therapeutics, Inc.
- Company name
- Anthos Therapeutics, Inc.
- Organisation type
- Industry
- Registered legal name
- ANTHOS THERAPEUTICS, INC.
- Registry sponsor category
- Industry
- Legal Entity Identifier (LEI)
- 549300E5DUQQTFH0IX39
Related records
Trials (6)
- A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation
- A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
- A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
- Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
- Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)